My thought is that bringing a new drug to market means completing phase II and phase III trials, then registering it (and jumping through all the FDA hoops along the way)... so yes, PAA has a human and animal cancer treatment but we still need LOTS of funds to get to the finish line ... so AUD$3B might be a tad high? I guess its about pricing the "potential" at this stage.
I do love the idea though, I'd take $9.52 !
PHARMAUST ALL SET FOR ELY LILLY T/O, page-54
-
- There are more pages in this discussion • 219 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 169572 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 613756 | 10 |
View Market Depth
| Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |